HCA Healthcare (HCA) Upgraded at Zacks Investment Research

HCA Healthcare (NYSE:HCA) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Tuesday, December 19th.

According to Zacks, “HCA Healthcare’s shares have outperformed the industry year to date. Its top line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. Nevertheless, the company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last few quarters. High level of bad debts and disappointing international business are the also plaguing the company.”

A number of other equities analysts have also commented on HCA. Robert W. Baird reissued a “buy” rating on shares of HCA Healthcare in a research note on Thursday, September 28th. ValuEngine upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Royal Bank of Canada restated an “outperform” rating and set a $90.00 price objective on shares of HCA Healthcare in a research report on Thursday, October 19th. BMO Capital Markets started coverage on HCA Healthcare in a report on Monday, October 16th. They issued an “outperform” rating and a $90.00 price target on the stock. Finally, Piper Jaffray Companies reiterated a “buy” rating and issued a $92.00 price target on shares of HCA Healthcare in a report on Wednesday, October 4th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have issued a buy rating to the stock. HCA Healthcare has an average rating of “Buy” and a consensus target price of $88.70.

Shares of HCA Healthcare (NYSE:HCA) traded up $1.83 on Tuesday, reaching $88.80. The company’s stock had a trading volume of 1,871,335 shares, compared to its average volume of 2,087,933. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. The stock has a market capitalization of $31,420.00, a PE ratio of 12.63, a price-to-earnings-growth ratio of 1.17 and a beta of 0.55. HCA Healthcare has a fifty-two week low of $71.18 and a fifty-two week high of $91.03.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.21. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The firm had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. During the same quarter in the prior year, the company posted $1.45 earnings per share. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. equities research analysts forecast that HCA Healthcare will post 6.56 EPS for the current year.

In other news, SVP Victor L. Campbell sold 8,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total transaction of $624,000.00. Following the transaction, the senior vice president now directly owns 127,275 shares in the company, valued at approximately $9,927,450. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the transaction, the insider now owns 12,476 shares in the company, valued at $973,128. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,700 shares of company stock worth $1,773,872. 2.90% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in HCA Healthcare by 0.7% in the second quarter. Vanguard Group Inc. now owns 19,718,250 shares of the company’s stock valued at $1,719,431,000 after purchasing an additional 141,258 shares during the period. Glenview Capital Management LLC increased its position in shares of HCA Healthcare by 2.6% during the second quarter. Glenview Capital Management LLC now owns 14,899,289 shares of the company’s stock worth $1,299,218,000 after acquiring an additional 384,024 shares during the period. Longview Partners Guernsey LTD increased its position in shares of HCA Healthcare by 22.6% during the third quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after acquiring an additional 2,053,701 shares during the period. LSV Asset Management increased its position in shares of HCA Healthcare by 5.5% during the second quarter. LSV Asset Management now owns 3,907,939 shares of the company’s stock worth $340,772,000 after acquiring an additional 203,290 shares during the period. Finally, APG Asset Management N.V. increased its position in shares of HCA Healthcare by 141.4% during the third quarter. APG Asset Management N.V. now owns 3,423,381 shares of the company’s stock worth $272,467,000 after acquiring an additional 2,005,193 shares during the period. 75.34% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: This piece was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another site, it was illegally copied and republished in violation of US & international copyright law. The legal version of this piece can be read at https://ledgergazette.com/2018/01/13/zacks-investment-research-upgrades-hca-healthcare-hca-to-hold.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply